• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 215/08 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom

Patent holdings for IPC class C07D 215/08

Total number of patents in this class: 118

10-year publication summary

8
11
7
7
10
9
3
5
2
3
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bayer AG
3522
9
Sanofi
4319
6
Conopco, Inc.
5092
4
Sumitomo Chemical Company, Limited
8968
4
Lead Pharma Holding B.V.
20
4
Bristol-myers Squibb Company
4757
3
Merck Sharp & Dohme Corp.
2183
3
Board of Regents, The University of Texas System
6141
3
Cytokinetics, Inc.
251
3
F. Hoffmann-La Roche AG
7808
2
Unilever PLC
2985
2
Unilever N.V.
2899
2
President and Fellows of Harvard College
6105
2
Northwestern University
3557
2
Astex Therapeutics Limited
207
2
Constellation Pharmaceuticals, Inc.
218
2
Fondazione Istituto Italiano di Tecnologia
632
2
Indiana University Research and Technology Corporation
782
2
SABIC Global Technologies B.V.
4611
2
Vilnius University
100
2
Other owners 57